Table 3 Univariate and multivariate analysis of prognostic factors of 5-year overall survival in NSCLC patients.
From: The potential of secretogranin V as a prognostic biomarker in non-small cell lung cancer
Characteristic | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
HR | 95% CI | P | HR | 95% CI | P | |
SCG5 expression Low vs. High | 0.318 | 0.163–0.621 | 0.001* | 0.387 | 0.155–0967 | 0.042* |
Gender Male vs. female | 0.538 | 0.288–1.004 | 0.051 | |||
Age (years) ≤ 60 vs. > 60 | 0.867 | 0.460–1.636 | 0.660 | |||
Smoke | 0.771 | 0.423–1.407 | 0.397 | |||
SI<400 | ||||||
SI ≥ 400 | ||||||
T | 0.221 | 0.098–0.496 | <0.001** | 0.407 | 0.168–0.983 | 0.046* |
T1T2 | ||||||
T3T4 | ||||||
N | 0.190 | 0.101–0.358 | <0.001** | 0.454 | 0.210–0.982 | 0.045* |
N0 | ||||||
N1N2N3 | ||||||
M | 0.133 | 0.070–0.249 | <0.001** | |||
M0 | ||||||
M1 | ||||||
TNM stage I/II vs. III/VI | 0.049 | 0.020–0.119 | < 0.001** | 0.142 | 0.043–0.474 | 0.001* |
Histology stage Well vs. poorly | 0.121 | 0.056–0.263 | < 0.001** | 0.261 | 0.094–0.724 | 0.010* |
